Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenerimod in hepatic impairment
NCT04819464Phase 1Completed
- Sponsor
- Viatris
- Start
- Aug 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, open-label trial of cenerimod (3 arms), sponsored by Viatris. Primary endpoints: Area under the plasma concentration-time curve from zero to time t, Area under the plasma concentration-time curve from zero to infinity and 6 more. Started Aug 2021; status: completed.
02
Drugs
cenerimod
Beyond the preview
Go deeper on NCT04819464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04819464.